Third Harmonic Bio Inc. is an innovative biotechnology company dedicated to advancing breakthrough therapies for severe immunological and inflammatory disorders. Utilizing its proprietary genetic engineering platform, the firm is developing a robust pipeline of drug candidates designed to address significant unmet medical needs within the biopharmaceutical sector. With a strong emphasis on scientific rigor and patient-centric solutions, Third Harmonic Bio is strategically positioned to transform treatment paradigms and enhance the quality of care for patients and healthcare providers alike. Show more
1700 MONTGOMERY STREET, SAN FRANCISCO, CA, UNITED STATES, 94111, San Francisco, CA, 94111, USA
Market Cap
242.8M
52 Wk Range
$5.38 - $5.38
Previous Close
$5.38
Open
$5.38
Volume
N/A
Day Range
$5.38 - $5.38
Enterprise Value
-25.82M
Cash
271.6M
Avg Qtr Burn
-13.48M
Insider Ownership
9.11%
Institutional Own.
80.12%
Qtr Updated
03/31/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
